Suppr超能文献

永久性透析导管患者导管相关感染的危险因素。

Risk factors for catheter-related infections in patients receiving permanent dialysis catheter.

机构信息

Department of Nephrology and Rheumatology, University Medical Center Göttingen, Georg-August-University, Robert-Koch-Str.40, 37099, Göttingen, Germany.

Department of Nephrology and Hypertension, Academic Teaching Hospital Bamberg, Bugerstrasse 80, 96049, Bamberg, Germany.

出版信息

BMC Nephrol. 2019 May 31;20(1):199. doi: 10.1186/s12882-019-1392-0.

Abstract

BACKGROUND

Due to rising vascular comorbidities of patients undergoing dialysis, the prevalence of permanent hemodialysis catheters as hemodialysis access is increasing. However, infection is a major complication of these catheters. Therefore, identification of potential predicting risk factors leading to early infection related complications is valuable, in particular the significance the CRP (C-reactive protein)-value is of interest.

METHODS

In this retrospective study 151 permanent hemodialysis catheters implanted in 130 patients were examined. The following data were collected at the time of catheter implantation: CRP-value, history of catheter-related infection, microbiological status, immunosuppression and diabetes mellitus. The primary outcomes were recorded over the 3 months following the implantation: catheter-related infection, days of hospital stay and death. Catheter removal or revision, rehospitalization and use of antibiotics were identified as secondary outcomes.

RESULTS

We identified a total of 27 (17.9%) infections (systemic infection: 2.26 episodes/ 1000 catheter days, local infection: 0.6 episodes/ 1000 catheter days). The development of an infection was independent of the CRP-value (p = 0.66) as well as the presence of diabetes mellitus (p = 0.64) or immunosuppression (p = 0.71). Univariate analysis revealed that infection was more frequent in patients with MRSA-carriage (p < 0.001), in case of previous catheter-related infection (p < 0.05) and of bacteremia or bacteriuria in the period of 3 months before catheter implantation (p < 0.001). Catheter removal or revision (p = 0.002), rehospitalization (p = 0.001) and use of antibiotics (p = 0.02) were also more often observed in patients with MRSA-carriage.

CONCLUSIONS

The CRP-value at the time of implantation of a permanent hemodialysis catheter is not associated with the development of early catheter related infections, but an individual history of catheter-related infection, MRSA-carriage and bacteremia or bacteriuria in the period of 3 months prior to catheter implantation are significant risk factors.

摘要

背景

由于接受透析治疗的患者血管合并症的增加,永久性血液透析导管作为血液透析通路的患病率正在增加。然而,感染是这些导管的主要并发症。因此,确定导致早期感染相关并发症的潜在预测风险因素是有价值的,特别是 CRP(C 反应蛋白)值的意义。

方法

在这项回顾性研究中,检查了 130 名患者的 151 个永久性血液透析导管。在导管植入时收集了以下数据:CRP 值、导管相关感染史、微生物状态、免疫抑制和糖尿病。主要结果记录在导管植入后 3 个月内:导管相关感染、住院天数和死亡。导管移除或修改、再次住院和使用抗生素被确定为次要结果。

结果

我们共发现 27 例(17.9%)感染(全身感染:每 1000 个导管日 2.26 例,局部感染:每 1000 个导管日 0.6 例)。感染的发生与 CRP 值无关(p=0.66),也与糖尿病(p=0.64)或免疫抑制(p=0.71)无关。单因素分析显示,在 MRSA 携带患者中感染更常见(p<0.001),在有导管相关感染史的患者中(p<0.05),以及在导管植入前 3 个月内有菌血症或菌尿的患者中(p<0.001)。在 MRSA 携带患者中,更常观察到导管移除或修改(p=0.002)、再次住院(p=0.001)和使用抗生素(p=0.02)。

结论

永久性血液透析导管植入时的 CRP 值与早期导管相关感染的发生无关,但导管相关感染史、MRSA 携带以及导管植入前 3 个月内的菌血症或菌尿是显著的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f884/6544915/ee8438a81cf1/12882_2019_1392_Fig1_HTML.jpg

相似文献

1
Risk factors for catheter-related infections in patients receiving permanent dialysis catheter.
BMC Nephrol. 2019 May 31;20(1):199. doi: 10.1186/s12882-019-1392-0.
3
6
Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias.
Nephron. 2002 Jul;91(3):399-405. doi: 10.1159/000064279.
7
Complications From Tunneled Hemodialysis Catheters: A Canadian Observational Cohort Study.
Am J Kidney Dis. 2019 Apr;73(4):467-475. doi: 10.1053/j.ajkd.2018.10.014. Epub 2019 Jan 12.
8
Use of iliac vein tunneled cuffed catheters in elderly hemodialysis patients: a single-center retrospective study.
J Nephrol. 2016 Feb;29(1):105-10. doi: 10.1007/s40620-015-0198-9. Epub 2015 May 13.
9
[Infections on catheters in hemodialysis: Temporal fluctuations of the infectious risk].
Nephrol Ther. 2017 Nov;13(6):463-469. doi: 10.1016/j.nephro.2017.01.021. Epub 2017 Sep 22.

引用本文的文献

1
Synergistic treatment of linoleic acid and cefazolin on biofilm-related catheter infections.
Appl Environ Microbiol. 2025 Jun 18;91(6):e0077025. doi: 10.1128/aem.00770-25. Epub 2025 May 21.
2
Incidence, Risk Factors, Organism Types, and Outcomes of Catheter-Related Bloodstream Infections in Hemodialysis Patients.
Cureus. 2024 Sep 16;16(9):e69554. doi: 10.7759/cureus.69554. eCollection 2024 Sep.
4
The evolving panorama of vascular access in the 21st century.
Front Nephrol. 2022 Oct 26;2:917265. doi: 10.3389/fneph.2022.917265. eCollection 2022.
6
Characterization of the Human Blood Virome in Iranian Multiple Transfused Patients.
Viruses. 2023 Jun 23;15(7):1425. doi: 10.3390/v15071425.
8
Epidemiology of haemodialysis outcomes.
Nat Rev Nephrol. 2022 Jun;18(6):378-395. doi: 10.1038/s41581-022-00542-7. Epub 2022 Feb 22.
9
Effect of sutureless securement on hemodialysis catheter-related bloodstream infection.
Sci Rep. 2021 Nov 5;11(1):21771. doi: 10.1038/s41598-021-01372-6.
10
Central Venous Disease Increases the Risk of Microbial Colonization in Hemodialysis Catheters.
Front Med (Lausanne). 2021 Aug 23;8:645539. doi: 10.3389/fmed.2021.645539. eCollection 2021.

本文引用的文献

1
US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States.
Am J Kidney Dis. 2015 Jul;66(1 Suppl 1):Svii, S1-305. doi: 10.1053/j.ajkd.2015.05.001.
2
Trends in incident hemodialysis access and mortality.
JAMA Surg. 2015 May;150(5):441-8. doi: 10.1001/jamasurg.2014.3484.
4
A Study of Inflammatory Status in Nephropathy Patients with History of Type-II Diabetes Mellitus Undergoing Haemodialysis.
J Clin Diagn Res. 2013 Oct;7(10):2143-5. doi: 10.7860/JCDR/2013/5833.3453. Epub 2013 Oct 5.
7
Temporal risk profile for infectious and noninfectious complications of hemodialysis access.
J Am Soc Nephrol. 2013 Oct;24(10):1668-77. doi: 10.1681/ASN.2012121234. Epub 2013 Jul 11.
9
Successful prevention of tunneled central catheter infection by antibiotic lock therapy using cefazolin and gentamicin.
Int Urol Nephrol. 2013 Oct;45(5):1405-13. doi: 10.1007/s11255-012-0339-1. Epub 2012 Dec 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验